The Salehs of Toronto say: "[Canada] is no longer liveable or a desirable place to be, at least not like it used to be."
A new version of a bill that would restrict U.S. business with China's WuXi AppTec, BGI and other biotechnology companies of concern would allow companies until 2032 to end work with the Chinese firms, extending the amount of time to find new partners. The latest Biosecure Act also adds WuXi Biologics to a list of biotech companies of concern. The other companies on the list are BGI, MGI, Complete Genomics and WuXi AppTec.
Moderna (MRNA) has announced a setback in the anticipated approval of its RSV vaccine. The biopharmaceutical company says that the US Food and Drug Administration (FDA) has postponed the decision to approve the vaccine until the end of May due to administrative constraints. Yahoo Finance's health reporter Anjalee Khemlani breaks down the details. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith